Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim Licenses BioMax's BioRS Software

NEW YORK (GenomeWeb News) — Boehringer Ingelheim will use BioMax’s BioRS Integration and Retrieval system as a data-integration platform to access public and private pharmaceutical information, BioMax said yesterday.
 
BioRS is designed to search multiple databases through web interfaces.
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.